Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?

• Published in: Lipids in health and disease Vol. 14; no. 1; p. 86
• Main Authors: Yeung, Emily N W, Treskes, Philipp, Martin, Sarah F, Manning, Jonathan R, Dunbar, Donald R, Rogers, Sophie M, Le Bihan, Thierry, Lockman, K Ann, Morley, Steven D, Hayes, Peter C, Nelson, Leonard J, Plevris, John N
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 10.08.2015; BioMed Central
• Subjects: Cardiovascular Diseases - etiology; Cell Line, Tumor; Complications and side effects; Farnesyl-Diphosphate Farnesyltransferase - metabolism; Fatty liver; Fibrinogen; Fibrinogen - biosynthesis; Genes; Genetic Association Studies; Health aspects; Humans; Models, Biological; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - genetics; Non-alcoholic Fatty Liver Disease - metabolism; Non-alcoholic Fatty Liver Disease - pathology; Oligonucleotide Array Sequence Analysis; Physiological aspects; Proteomics; Risk Factors; Signal Transduction; Up-Regulation
• ISSN: 1476-511X; 1476-511X
• DOI: 10.1186/s12944-015-0069-3

Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorbidities often found in NAFLD patients, by using an established in-vitro model of hepatic steatosis. Histopathological events in non-alcoholic fatty liver disease were recapitulated by focused metabolic nutrient overload of hepatoblastoma C3A cells, using oleate-treated-cells and untreated controls for comparison. Microarray and proteomic data from cell culture experiments were integrated into a custom-built systems biology database and proteogenomics analysis performed. Candidate genes with significant dysregulation and concomitant changes in protein abundance were identified and STRING association and enrichment analysis performed to identify putative pathogenic pathways. The search strategy yielded 3 candidate genes that were specifically and significantly up-regulated in nutrient-overloaded cells compared to untreated controls: fibrinogen alpha chain (2.2 fold), fibrinogen beta chain (2.3 fold) and fibrinogen gamma chain (2.1 fold) (all rank products pfp <0.05). Fibrinogen alpha and gamma chain also demonstrated significant concomitant increases in protein abundance (3.8-fold and 2.0-fold, respectively, p <0.05). In-vitro modelling of NAFLD and reactive oxygen species formation in nutrient overloaded C3A cells, in the absence of pathogenic influences from other comorbidities, suggests that NAFLD is an isolated determinant of CVD. Nutrient overload-induced up-regulation of all three fibrinogen component subunits of the coagulation cascade provides a possible mechanism to explain the excess CVD mortality observed in NAFLD patients.